---
title: "\"Virtual Reality\" completes A+ round investment of over 50 million yuan"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/273803039.md"
description: "36Kr learned that the AI medical innovation company \"Xu Zhi Shi\" announced that it completed its A+ round of financing by the end of 2025, with a financing amount exceeding 50 million yuan. This round of financing was jointly invested by Zhejiang Merchants Capital, Xiangtai Capital, and Plum Ventures, and will focus on the construction of AI algorithm systems for brain-specific diseases, multimodal neural data modeling, accumulation of physical AI training data, and the research and development of XR-type brain-computer interface hardware. Xu Zhi Shi further stated that the company's B round of financing is currently in active preparation and is expected to officially launch after the Spring Festival"
datetime: "2026-01-27T07:20:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273803039.md)
  - [en](https://longbridge.com/en/news/273803039.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273803039.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/273803039.md) | [繁體中文](https://longbridge.com/zh-HK/news/273803039.md)


# "Virtual Reality" completes A+ round investment of over 50 million yuan

36Kr learned that the AI medical innovation company "Virtual Reality" announced that it completed its A+ round of financing by the end of 2025, with a financing amount exceeding 50 million yuan. This round of financing was jointly invested by Zhejiang Merchants Capital, Xiangtai Capital, and Plum Ventures, and will focus on the construction of AI algorithm systems for brain-specific diseases, multimodal neural data modeling, accumulation of physical AI training data, and the research and development of XR-type brain-computer interface hardware. Virtual Reality further stated that the company's B round of financing is currently in active preparation and is expected to officially launch after the Spring Festival

### 相关股票

- [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/zh-CN/quote/516500.CN.md)
- [CS精准医 (000863.CN)](https://longbridge.com/zh-CN/quote/000863.CN.md)
- [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/zh-CN/quote/516930.CN.md)
- [Junshi Biosciences (688180.CN)](https://longbridge.com/zh-CN/quote/688180.CN.md)
- [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/zh-CN/quote/159849.CN.md)
- [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/zh-CN/quote/159837.CN.md)

## 相关资讯与研究

- [22:54 ETHugel to enter ECM-based injectable market with aesthetic portfolio expansion](https://longbridge.com/zh-CN/news/281291767.md)
- [Biocytogen and Sihuan partner to advance new therapeutics for weight loss](https://longbridge.com/zh-CN/news/281501537.md)
- [MedPal AI Wins Strong Shareholder Backing at AGM as It Expands AI Health Platform](https://longbridge.com/zh-CN/news/281501359.md)
- [08:05 ETPenguin Ai Launches Gwen, a Build-Your-Own AI Platform for Healthcare Operations](https://longbridge.com/zh-CN/news/281363782.md)
- [Tempus AI, Medtronic Report Positive Clinical Trial Results for Medical Alert System](https://longbridge.com/zh-CN/news/281383602.md)